Fennec Pharmaceuticals Inc. (FENC) NASDAQ
6.42
+0.01(+0.16%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.42
+0.01(+0.16%)
Currency In USD
| Market Cap | 220.04M |
| Enterprise Value | 183.32M |
| P/E Ratio | -19.66 |
| PEG Ratio | 0.51 |
| Price/Sales Ratio | 4.09 |
| Price/Book Ratio | 5.71 |
| Enterprise/Revenue | 3.27 |
| Enterprise/EBITDA | -23.01 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.23 |
| Operating Margin | -0.15 |
| Return On Assets | -0.15 |
| Return On Equity | -2.36 |
| Revenue | 45.42M |
| Revenue/Share | 1.44 |
| Gross Profit | 41.59M |
| EBITDA | -6.86M |
| Net Income | -10.27M |
| Diluted EPS | -0.36 |
| Total Cash | 36.72M |
| Total Cash/Share | 1.18 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 6.34 |
| Book Value Per Share | 1.12 |
| 52-Week Change | 14.85 |
| 52-Week High | 9.92 |
| 52-Week Low | 4.68 |
| Moving Average 50 Days | 7.71 |
| Moving Average 200 Days | 8.18 |
| Average Volume | 158,885 |
| Shares Outstanding | 28.58M |
| % Held by Institutions | 55.72 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
| Last Split Date | September 09, 2014 |